Company Overview

Javelin Pharmaceuticals, Inc., a development stage company, engages in the research, development, and commercialization of treatments for the relief of moderate to severe pain primarily in the United States and Europe. Its product line primarily includes Dyloject, an injectable diclofenac; Ereska, an intranasal ketamine; and Rylomine, an intranasal morphine that completed the phase III development stage. The company offers its products for treating various pain disorders, such as acute and episodic moderate-to-severe pain associated with breakthrough cancer pain; post-operative pain; and post-trauma pain, such as orthopedic injury pain, procedural pain, and burn pain. Javelin Pharmaceuticals...

Javelin Pharmaceuticals, Inc., a development stage company, engages in the research, development, and commercialization of treatments for the relief of moderate to severe pain primarily in the United States and Europe. Its product line primarily includes Dyloject, an injectable diclofenac; Ereska, an intranasal ketamine; and Rylomine, an intranasal morphine that completed the phase III development stage. The company offers its products for treating various pain disorders, such as acute and episodic moderate-to-severe pain associated with breakthrough cancer pain; post-operative pain; and post-trauma pain, such as orthopedic injury pain, procedural pain, and burn pain. Javelin Pharmaceuticals has license agreements with Shimoda Biotech, Ltd. to develop and commercialize products related to a proprietary formulation of the injectable delivery of diclofenac; and West Pharmaceutical Services, Inc. to develop and commercialize intranasal morphine for the transmucosal delivery of morphine to humans and animals for the treatment of pain. The company was formerly known as Intrac, Inc. and changed its name to Javelin Pharmaceuticals, Inc. in September 2005. The company was founded in 1998 and is based in Cambridge, Massachusetts. As of June 30, 2010, Javelin Pharmaceuticals, Inc. operates as a subsidiary of Hospira Inc.

Key Executives for Javelin Pharmaceuticals, Inc.

Similar Private Companies By Industry

Recent Private Companies Transactions